Cargando…
Drug Targeting of NR4A Nuclear Receptors for Treatment of Acute Myeloid Leukemia
NR4As are AML tumor suppressors that are frequently silenced in human AML. Despite their potential as novel targets for therapeutic intervention, mechanisms of NR4A silencing and strategies for their reactivation remain poorly defined. Here we show that NR4A silencing in AML occurs through blockade...
Autores principales: | Boudreaux, Seth P., Duren, Ryan P., Call, Steven G., Nguyen, Loc, Freire, Pablo R, Narayanan, Padmini, Redell, Michele S., Conneely, Orla M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6286710/ https://www.ncbi.nlm.nih.gov/pubmed/29884904 http://dx.doi.org/10.1038/s41375-018-0174-1 |
Ejemplares similares
-
Genome Wide Mapping of NR4A Binding Reveals Cooperativity with ETS Factors to Promote Epigenetic Activation of Distal Enhancers in Acute Myeloid Leukemia Cells
por: Duren, Ryan P., et al.
Publicado: (2016) -
Targeting Oncogenic Super Enhancers in MYC-Dependent AML Using a Small Molecule Activator of NR4A Nuclear Receptors
por: Call, S. Greg, et al.
Publicado: (2020) -
Genome-wide profiling reveals transcriptional repression of MYC as a core component of NR4A tumor suppression in acute myeloid leukemia
por: Boudreaux, S P, et al.
Publicado: (2012) -
Glucocorticoids Inhibit Oncogenic RUNX1-ETO in Acute Myeloid Leukemia with Chromosome Translocation t(8;21)
por: Lu, Lianghao, et al.
Publicado: (2018) -
Nuclear Receptor 4a3 (Nr4a3) Regulates Murine Mast Cell Responses and Granule Content
por: Garcia-Faroldi, Gianni, et al.
Publicado: (2014)